Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 29 most recent Form 4 transactions.
| Mar 23 | CRSP | CRISPR Therapeutics AG | SSELL | 3,708 | $46.78 | $173.5K | -19.2% | Open the original filing on SEC.gov |
| Mar 20 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 6,250 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 27,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 38,499 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | CRSP | CRISPR Therapeutics AG | MEXER | 6,250 | — | — | +48.0% | Open the original filing on SEC.gov |
| Mar 16 | CRSP | CRISPR Therapeutics AG | GGIFT | 750 | — | — | -5.5% | Open the original filing on SEC.gov |
| Mar 16 | CRSP | CRISPR Therapeutics AG | SSELL | 4,021 | $48.26 | $194.1K | -22.6% | Open the original filing on SEC.gov |
| Mar 16 | CRSP | CRISPR Therapeutics AG | SSELL | 5,848 | $48.26 | $282.2K | -24.7% | Open the original filing on SEC.gov |
| Mar 14 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 6,875 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | CRSP | CRISPR Therapeutics AG | MEXER | 6,875 | — | — | +41.0% | Open the original filing on SEC.gov |
| Mar 14 | CRSP | CRISPR Therapeutics AG | MEXER | 10,000 | — | — | +147.8% | Open the original filing on SEC.gov |
| Jan 22 | CRSP | CRISPR Therapeutics AG | MEXER◷◆ | 34,972 | — | — | — | Open the original filing on SEC.gov |
| Jan 22 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 34,972 | $60.19 | $2.1M | -83.8% | Open the original filing on SEC.gov |
| Jan 22 | CRSP | CRISPR Therapeutics AG | MEXER◷ | 34,972 | $45.15 | $1.6M | +516.8% | Open the original filing on SEC.gov |
| Jan 6 | CRSP | CRISPR Therapeutics AG | MEXER◷◆ | 6,339 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | CRSP | CRISPR Therapeutics AG | MEXER◷◆ | 23,361 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 5,763 | $60.21 | $347K | -46.0% | Open the original filing on SEC.gov |
| Jan 6 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 5,004 | $60.00 | $300.2K | -28.5% | Open the original filing on SEC.gov |
| Jan 6 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 18,933 | $60.18 | $1.1M | -51.9% | Open the original filing on SEC.gov |
| Jan 6 | CRSP | CRISPR Therapeutics AG | MEXER◷ | 6,339 | $44.31 | $280.9K | +21.0% | Open the original filing on SEC.gov |
| Jan 6 | CRSP | CRISPR Therapeutics AG | MEXER◷ | 23,361 | $45.15 | $1.1M | +345.2% | Open the original filing on SEC.gov |
| Dec 22, 2025 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 1,000 | $56.89 | $56.9K | -12.9% | Open the original filing on SEC.gov |
| Dec 22, 2025 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 5,472 | $56.33 | $308.3K | -41.3% | Open the original filing on SEC.gov |
| Dec 22, 2025 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 3,528 | $55.10 | $194.4K | -21.0% | Open the original filing on SEC.gov |
| Oct 3, 2025 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 16,500 | — | — | — | Open the original filing on SEC.gov |
| May 30, 2025 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |